Relevance of an evidence-based ejaculation time cutoff point for neurobiological research of premature ejaculation

Journal of Comparative Neurology

Volumn 493, Issue 1, 2005, Pages 46-50

  Waldinger, Marcel D ^a,b  

^a HagaHospital Leyenburg The Hague ^*  (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Definition; Epidemiology; Premature ejaculation; SSRI

Indexed keywords

CLOMIPRAMINE; SEROTONIN UPTAKE INHIBITOR;

CONFERENCE PAPER; ENVIRONMENTAL FACTOR; EVIDENCE BASED MEDICINE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LATENT PERIOD; MALE; NEUROBIOLOGY; NONHUMAN; PHENOTYPE; PREMATURE EJACULATION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RAT;

ANIMALS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EJACULATION; EVIDENCE-BASED MEDICINE; HUMANS; MALE; MODELS, ANIMAL; RESEARCH DESIGN; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 27744457380     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.20718     Document Type: Conference Paper

References (23)

1. Ahlenius S, Larsson K, Svensson L, Hjorth S, Carlsson A, Linberg P, Wikstrom H, Sanchez D, Arvidsson LE, Hacksell U, Nilsson JL. 1981. Effects of a new type of 5-HT receptor agonist on male rat sexual behavior. Pharmacol Biochem Behav 15:785-792.
2. APA (American Psychiatric Association). 1994. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association.
3. Cooper AJ. 1969. Clinical and therapeutic studies in premature ejaculation. Compr Psychiatry 10:285-295.
4. Foreman MM, Hall JL, Love RL. 1989. The role of the 5-HT2 receptor in the regulation of sexual performance of male rats. Life Sci 45:1263-1270.
5. Masters WH, Johnson VE. 1970. Premature ejaculation. In: Masters WH, Johnson VE, eds. Human sexual inadequacy. Boston: Little, Brown. p 92-115.
6. Mos J, Mollet I, Tolboom JTBM, Waldinger MD, Olivier B. 1999. A comparison of the effects of different serotonin reuptake blockers on sexual behavior of the male rat. Eur Neuropsychopharmacol 9:123-135.
7. Obuchowski NA (ed.). 2002. Statistical methods in diagnostic medicine. Wiley Series in Probability and Statistics. New York: Wiley-Interscience.
8. Olivier B, van Oorschot R, Waldinger MD. 1998. Serotonin, serotonergic receptors, selective serotonin reuptake inhibitors and sexual behaviuor. Int Clin Psychopharmacol 13(Suppl 6):S9-S14.
9. Olivier B, Chan J, Pattij T, de Jong T, Oosting R, Veening J, Waldinger MD. 2005. Psycho-pharmacology of male rat sexual behavior: modeling human sexual dysfunctions? Int J Impot Res (April E-pub).
10. Patrick DL, Althof SE, Pryor JL, Rosen R, Rowland DL, Ho KF, McNulty P, Rothman M, Jamieson C. 2005. Premature ejaculation: an observational study of men and their partners. J Sex Med 2:358-367.
11. Pattij T, de Jong T, Uitterdijk A, Waldinger MD, Veening JG, van der Graaf PH, Olivier B. 2005. Individual differences in male rat ejaculatory behaviour: searching for models to study ejaculation disorders. Eur J Neuroscience 22:724-34.
12. Rowland DL. 1998. Penile sensitivity in men: a composite of recent findings. Urology 52:1101-1105.
13. Waldinger MD. 2002. The neurobiological approach to premature ejaculation(Review). J Urol 168:2359-2367.
14. Waldinger MD. 2004. Lifelong premature ejaculation: from authority-based to evidence-based medicine. BJU Int 93:201-207.
15. Waldinger MD, Olivier B. 2000. Selective serotonin reuptake inhibitors (SSRIs) and sexual side effects: differences in delaying ejaculation. In: Sacchetti E, Spano P, editors. Advances in preclinical and clinical psychiatry, vol. I. Fluvoxamine: established and emerging roles in psychiatric disorders. Milan, Italy: Excerpta Medica. p 117-130.
16. Waldinger MD, Olivier B. 2005. Animal models of premature and delayed ejaculation. World J Urol 23:115-118.
17. Waldinger MD, Hengeveld MW, Zwinderman AH. 1994. Paroxetine treatment of premature ejaculation: a double-blind, randomised, placebo-controlled study. Am J Psychiatry 151:1377-1379.
18. Waldinger MD, Berendsen HHG, Blok BFM, Olivier B, Holstege G. 1998a. Premature ejaculation and SSRI-induced delayed ejaculation: the involvement of the serotonergic system. Behav Brain Res 92:111-118.
19. Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B. 1998b. An empirical operationalization study of DSM-IV diagnostic criteria for premature ejaculation. Int J Psychiatry Clin Pract 2:287-293.
20. Waldinger MD, Zwinderman AH, Schweitzer DH, Olivier B. 2004. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. J Impot Res 16:369-381.
21. Waldinger MD, Schweitzer DH, Olivier B. 2005a. On-demand SSRI treatment of premature ejaculation: pharmacodynamic limitations for relevant ejaculation delay and consequent solutions. J Sex Med 2:121-131.
22. Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M. 2005b. A multinational population survey of intravaginal ejaculation latency time. J Sex Med 2:492-497.
23. Waldinger MD, Zwinderman AH, Olivier B, Schweitzer DH. 2005c. Proposal for a definition of lifelong premature ejaculation based on epidemiological stopwatch data. J Sex Med 2:498-507.